1. Hurthle Cell Carcinoma of the Thyroid: A Case Report of 12 Cases
- Author
-
Ju Yong Kang, Myung Chul Lee, Jung Jun Kim, and Ik Joon Choi
- Subjects
Pathology ,medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Thyroid ,Thyroidectomy ,030209 endocrinology & metabolism ,digestive system diseases ,Thyroid carcinoma ,03 medical and health sciences ,0302 clinical medicine ,medicine.anatomical_structure ,Otorhinolaryngology ,030220 oncology & carcinogenesis ,Medicine ,Surgery ,Hurthle cell carcinoma ,business ,neoplasms - Abstract
Hurthle cell carcinoma (HCC) is a relatively rare disease, which comprises about 3% of differentiated thyroid carcinoma. HCC is considered to have more aggressive clinical behavior compared with other differentiated thyroid carcinoma. However, there has been no consensus about clinical behavior and optimal treatment of HCC because of insufficient reports. Moreover, owing to geographical characteristics, HCC is rarer in Korea than in western countries. Based on 2017 World Health Organization classification, HCC is newly classified as an individual group, not as a subtype of follicular thyroid carcinoma. Therefore, we report data of 12 HCC patients who underwent surgery in our center from January 2000 to May 2020 with a review of the literature.
- Published
- 2020
- Full Text
- View/download PDF